CDNA Q2 2024 Earnings — CareDx, Inc Revenue & Financial Results | Market Cap Arena

CDNACareDx, Inc

$889M

Q2 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$92M+31.3% YoY

Gross Profit

$64M69.7% margin

Operating Income

-$7M-7.9% margin

Net Income

-$5M-5.0% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+28.1%

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

$17M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$467M

Total Liabilities

$202M

Stockholders' Equity

$265M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$92M	$70M	+31.3%
Gross Profit	$64M	$44M	+44.7%
Operating Income	-$7M	-$28M	+73.5%
Net Income	-$5M	-$25M	+81.5%

Revenue Segments

Service

$71M87%

Product

$11M13%

Geographic Segments

UNITED STATES

$88M95%

Europe

$3M3%

Rest Of The World

$1M2%